Korosteleva T A, Rabkova L M, Belokhvostova A T, Movsesian K S, Skadova V M
Vopr Onkol. 1986;32(9):48-53.
Immunologic vigor and 3-hydroxyanthranilic acid (3-HAA)-antigen level were studied in patients with urinary bladder cancer. Leukocyte migration inhibition test demonstrated the inhibitory effect of the said antigen on leukocyte migration in patients with early stage cancer. As tumor advanced, the process accelerated. The 3-HAA-antigen-containing blood serum of bladder cancer patients inhibited the synthesis of rosette-forming cells and antibodies to sheep erythrocytes. A correlation was established between the suppressive effect and tumor stage.
对膀胱癌患者的免疫活力和3-羟基邻氨基苯甲酸（3-HAA）抗原水平进行了研究。白细胞迁移抑制试验表明，该抗原对早期癌症患者的白细胞迁移有抑制作用。随着肿瘤进展，这一过程加快。膀胱癌患者含3-HAA抗原的血清抑制了玫瑰花结形成细胞的合成以及针对绵羊红细胞的抗体。在抑制作用与肿瘤分期之间建立了相关性。
